H2O Innovation Announces Pricing of Overnight Marketed Financings
– NOT FOR DISSEMINATION IN THE UNITED STATES OR TO UNITED STATES NEWSWIRE SERVICES. –All amounts are in Canadian dollars […]
DIAGNOS and its Local Partner Selected Following a Competitive Bid from the Mexican Government
BROSSARD, Québec, Oct. 29, 2019 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a […]
Relevium Enters Into LOI to Unlock Value of Wholly Owned Subsidiary BGX E-Health LLC and Announces Conference Call With CEO
MONTREAL, Oct. 29, 2019 (GLOBE NEWSWIRE) — Relevium Technologies Inc. (TSX.V: “RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), […]
PowerOne Capital Corp Acquires Shares of White Gold Corp.
TORONTO, Oct. 29, 2019 (GLOBE NEWSWIRE) — PowerOne Capital Corp., a joint actor (the “Joint Actor”) of Pat DiCapo (the […]
White Gold Corp. Receives $3.35 Million From Warrant Exercise
TORONTO, Oct. 29, 2019 (GLOBE NEWSWIRE) — White Gold Corp. (TSX.V: WGO, OTC – Nasdaq Intl: WHGOF, FRA: 29W) (the […]
Eguana Receives $1.8M in New Orders, Hawaiian Market Continues to Accelerate
CALGARY, Alberta, Oct. 29, 2019 (GLOBE NEWSWIRE) — Eguana Technologies (TSX.V: EGT) (OTCQB: EGTYF) is pleased to announce the receipt […]
Magna Terra Arranges Credit Agreement for $700,000
TORONTO, Oct. 29, 2019 (GLOBE NEWSWIRE) — Magna Terra Minerals Inc. (the “Company” or “Magna Terra”) (TSX-V: MTT) and Thorsen-Fordyce […]
Mission Ready Responds to Increased Market Activity
VANCOUVER, British Columbia, Oct. 29, 2019 (GLOBE NEWSWIRE) — Mission Ready Solutions Inc. (“Mission Ready” or the “Company”) (TSXV: MRS) […]
Pascal Biosciences and Y-Biologics Announce Research Collaboration for Development of a Bispecific Antibody for Leukemia
VANCOUVER, British Columbia and SEATTLE and DAEJON, Korea, Oct. 29, 2019 (GLOBE NEWSWIRE) — Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal”) and Y-Biologics […]
Ceapro Inc. Announces Issuance of U.S. and European Patent for Flagship Product, Avenanthramides
EDMONTON, Alberta, Oct. 29, 2019 (GLOBE NEWSWIRE) — Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“Ceapro” or the “Company”), a growth-stage biotechnology […]
